148 related articles for article (PubMed ID: 41191)
21. Characterization by [3H]dihydroergocryptine binding of alpha-adrenergic receptors in neuroblastoma X glioma hybrid cells.
Haga T; Haga K
J Neurochem; 1981 Mar; 36(3):1152-9. PubMed ID: 6110704
[TBL] [Abstract][Full Text] [Related]
22. Characterization of [3H]rauwolscine binding to alpha 2-adrenoceptor sites in the lumbar spinal cord of the cat: comparison to such binding sites in the cat frontal cerebral cortex.
Howe JR; Yaksh TL
Brain Res; 1986 Mar; 368(1):87-100. PubMed ID: 2869820
[TBL] [Abstract][Full Text] [Related]
23. Characterization of alpha 2-adrenergic receptors in human platelets by binding of a radioactive ligand [3H]yohimbine.
Mukherjee A
Biochim Biophys Acta; 1981 Aug; 676(2):148-54. PubMed ID: 6114754
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of beta-adrenergic-agonist binding to rat adipocyte membranes. Evidence that (+/-)-[3H]hydroxybenzylisoproterenol interacts selectively with the adipocyte beta-adrenergic receptors.
Giudicelli Y; Lacasa D; Agli B
Biochim Biophys Acta; 1982 Mar; 715(1):105-15. PubMed ID: 6122470
[TBL] [Abstract][Full Text] [Related]
25. Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.
Aggerbeck M; Guellaen G; Hanoune J
Br J Pharmacol; 1978 Apr; 62(4):543-8. PubMed ID: 26446
[TBL] [Abstract][Full Text] [Related]
26. Differential labeling of platelet alpha 2 adrenoceptors by 3H dihydroergocryptine and 3H yohimbine in patients with myeloproliferative disorders.
Swart SS; Wood JK; Barnett DB
Thromb Res; 1985 Dec; 40(5):623-9. PubMed ID: 3003960
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological characteristics of beta-adrenoceptor binding sites in intact and sympathectomized rat spleen.
Nahorski SR; Barnett DB; Howlett DR; Rugg EL
Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 307(3):227-33. PubMed ID: 226895
[TBL] [Abstract][Full Text] [Related]
28. Identification of alpha 2-adrenoceptors and non-adrenergic idazoxan binding sites in rabbit colon epithelial cells.
Senard JM; Langin D; Estan L; Paris H
Eur J Pharmacol; 1990 Nov; 191(1):59-68. PubMed ID: 1982658
[TBL] [Abstract][Full Text] [Related]
29. Alpha-adrenergic receptor identification by (3H)dihydroergocryptine binding.
Williams LT; Lefkowitz RJ
Science; 1976 May; 192(4241):791-3. PubMed ID: 4894
[TBL] [Abstract][Full Text] [Related]
30. Labelling of human platelet alpha 2-adrenoceptors with the full agonist [3H](-)adrenaline.
Garcia-Sevilla JA; Fuster MJ
Eur J Pharmacol; 1986 May; 124(1-2):31-41. PubMed ID: 3013661
[TBL] [Abstract][Full Text] [Related]
31. [3H]Dihydroergocryptine binding to alpha-adrenergic receptors of human platelets. A reassessment using the selective radioligands [3H]prazosin, [3H]yohimbine, and [3H]rauwolscine.
Motulsky HJ; Insel PA
Biochem Pharmacol; 1982 Aug; 31(16):2591-7. PubMed ID: 6291538
[TBL] [Abstract][Full Text] [Related]
32. Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.
Carpéné C; Galitzky J; Larrouy D; Langin D; Lafontan M
Biochem Pharmacol; 1990 Aug; 40(3):437-45. PubMed ID: 1974423
[TBL] [Abstract][Full Text] [Related]
33. New detection of brain dopamine receptors with (3H)dihydroergocryptine.
Tittler M; Weinreich P; Seeman P
Proc Natl Acad Sci U S A; 1977 Sep; 74(9):3750-3. PubMed ID: 410026
[TBL] [Abstract][Full Text] [Related]
34. Alpha 2-adrenoceptors in human lymphocytes: direct characterisation by [3H]yohimbine binding.
Titinchi S; Clark B
Biochem Biophys Res Commun; 1984 May; 121(1):1-7. PubMed ID: 6145413
[TBL] [Abstract][Full Text] [Related]
35. Affinities for alpha- and beta-adrenoceptor subtypes of YM-09538, a new combined alpha- and beta-adrenoceptor antagonist, by radioligand binding assay.
Asano M; Hashimoto H; Nakashima M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):34-46. PubMed ID: 6135396
[TBL] [Abstract][Full Text] [Related]
36. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
Zonnenchein R; Diamant S; Atlas D
Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
[TBL] [Abstract][Full Text] [Related]
37. Characterization of alpha-1 adrenergic receptors in the heart using [3H]WB4101: effect of 6-hydroxydopamine treatment.
Yamada S; Yamamura HI; Roeske WR
J Pharmacol Exp Ther; 1980 Oct; 215(1):176-85. PubMed ID: 6109014
[TBL] [Abstract][Full Text] [Related]
38. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
39. [3H]dihydroergocryptine binding in rat brain.
Davis JN; Strittmatter WJ; Hoyler E; Leefkowitz RJ
Brain Res; 1977 Aug; 132(2):327-36. PubMed ID: 196714
[TBL] [Abstract][Full Text] [Related]
40. Identification and characterization of adrenergic receptors and catecholamine-stimulated adenylate cyclase in hog pial membranes.
Friedman AH; Davis JN
Brain Res; 1980 Feb; 183(1):89-102. PubMed ID: 6244051
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
